HIGHLIGHTS
- who: Nana Tao and collaborators from the School of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Hangzhou, China have published the Article: Thymosin 1 and Its Role in Viral Infectious Diseases: The Mechanism and Clinical Application, in the Journal: Molecules 2023, 3539 of 16/04/2023
- how: The experimental results showed that the SVR rate of the Tu03b11 combined treatment group was significantly higher than that of the control group (41.0% vs. 26.3% p and amplt 0.05) and there was no significant difference in the incidence of adverse events among different groups which . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.